Bleomycin Sulfate

硫酸博来霉素

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameBleomycin Sulfate
Drug Alias Name硫酸争光霉素bleomicinableomycinum硫酸博莱霉素博来霉素硫酸盐 +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionDNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsSkin MelanomaVascular MalformationsHead and Neck Neoplasms +[6] 
Global Approved IndicationsNeoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1973/07/31
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Oncology Ljubljana
Inactive CompaniesInovio Pharmaceuticals IncH Lee Moffitt Cancer Center & Research InstituteNational Cancer Institute +[5] 
Active IndicationsVascular Malformations
Inactive IndicationsSkin MelanomaHead and Neck NeoplasmsPancreatic Neoplasms +[5] 

Other Information

ATC CodeL01DC01
Related LinksWikipediaDrugBankKEGG